Experimental CAR-T therapy for rare solid tumors stalls after single patient
Disease control
Terminated
This early-phase trial tested a personalized cell therapy called anti-ALPP CAR-T cells in people with advanced solid tumors that have the ALPP protein. Only one participant was enrolled before the study was terminated. The main goal was to check safety and find the right dose, no…
Phase: EARLY_PHASE1 • Sponsor: Haifeng Qin • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC